Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
B. Braun Medical Inc. is recalling specific lots of Cefazolin Sodium injectable products because visible particulate matter was found in reserve sample units.
B. Braun Medical Inc. is recalling Ceftriaxone for Injection and Dextrose Injection due to visible particulate matter found in reserve sample units.
John W Hollis Inc is recalling 3 vials of Polidocanol 3% Solution due to the presence of particulate matter. The product was distributed in Missouri, Tennessee, Mississippi, and Wisconsin.
B. Braun Medical Inc. is recalling 6.9% FreAmine HBC (Amino Acid Injection) units due to visible particulate matter found in reserve samples.
B. Braun Medical Inc. is recalling Hyperlyte CR injectable products because visible particulate matter was found in reserve sample units.
B. Braun Medical Inc. is recalling Cefoxitin and Dextrose injectable products due to visible particulate matter found in reserve sample units.
B. Braun Medical Inc. is recalling 0.9% Sodium Chloride Injection USP due to visible particulate matter found in reserve samples.
Hospira Inc. is recalling Lidocaine Hydrochloride Injection due to confirmed particulate matter in the glass containers.
B. Braun Medical Inc. is recalling ProcalAmine injectable products due to visible particulate matter found in reserve samples.
AbbVie is recalling 36 kits of Lupron Depot 45 mg due to a potentially defective needle stick protection device.
Dolphin Intertrade Corporation is recalling JaDera weight loss capsules because they contain undeclared sibutramine, a drug removed from the U.S. market for safety reasons.
Fossil Fuel Products, LLC is recalling RezzRX capsules because they contain undeclared hydroxylthiohomosildenafil and aminotadalafil.
Dolphin Intertrade Corporation is recalling XIYOUJI QINGZHI CAPSULES because they contain undeclared sibutramine, a substance removed from the U.S. market for safety reasons.
Shire Human Genetic Therapies is recalling 8,359 vials of VPRIV (velaglucerase alfa) because they contain stainless steel and barium sulfate particles.
Brookfield Prescription Center Inc. is recalling one lot of Glycopyrrolate solution for injection due to Bacillus thuringiensis contamination.
Hospira is recalling 255,900 vials of Potassium Chloride for Injection due to the presence of red and black particulate matter identified as iron oxide.
Haute Health is recalling Virilis Pro dietary supplements because they may contain unapproved active ingredients found in FDA-approved erectile dysfunction drugs.
B @ B Trade Inc. is recalling Slim Expert softgels because they contain undeclared sibutramine and were marketed without FDA approval.
B @ B Trade Inc. is recalling Slim Fortune capsules because they contain undeclared sibutramine and were marketed without FDA approval.
Haute Health, LLC is recalling PHUK Sexual Enhancement Ultimate Pleasure because it may contain unapproved active ingredients found in FDA-approved erectile dysfunction drugs.
Hospira, Inc. is recalling 1% Lidocaine Hydrochloride Injection vials because oxidized stainless steel was found in the product.
B @ B Trade Inc. is recalling Lidiy capsules because the dietary supplement was marketed without FDA approval and contains undeclared sibutramine.
Haute Health, LLC is recalling Prolifta dietary supplements because they may contain unapproved active ingredients used in erectile dysfunction drugs.
Slim Beauty USA is recalling Dream Body Slimming Capsules because they contain undeclared sibutramine, an unapproved new drug not currently marketed in the United States.
Slim Beauty USA is recalling Dr. Ming's Chinese Capsule because it contains undeclared sibutramine and phenolphthalein, making it an unapproved new drug.